Pulmonx (LUNG) Non-Current Deferred Tax Liability (2019 - 2025)
Pulmonx (LUNG) reported Non-Current Deferred Tax Liability of $69000.0 for Q4 2025, down 20.69% year-over-year from $87000.0 in Q4 2024, and up 46.81% on a QoQ basis from $47000.0 in Q3 2025.
Pulmonx (LUNG) has 7 years of Non-Current Deferred Tax Liability data on file, last reported at $69000.0 in Q4 2025.
- Quarterly Non-Current Deferred Tax Liability fell 20.69% year-over-year to $69000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $69000.0 (down 20.69% YoY) and the FY2025 annual result came in at $69000.0, down 20.69% from the prior year.
- Non-Current Deferred Tax Liability climbed to $69000.0 in Q4 2025 per LUNG's latest filing, from $47000.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $140000.0 in Q1 2024 and bottomed at $37000.0 in Q4 2021.
- The 5-year median for Non-Current Deferred Tax Liability is $71000.0 (2021), against an average of $79000.0.
- The widest annual swing landed in 2022, when Non-Current Deferred Tax Liability jumped 154.05%; it then sank 65.25% in 2025.
- Tracing LUNG's Non-Current Deferred Tax Liability over 5 years: stood at $37000.0 in 2021, then surged by 154.05% to $94000.0 in 2022, then grew by 21.28% to $114000.0 in 2023, then dropped by 23.68% to $87000.0 in 2024, then decreased by 20.69% to $69000.0 in 2025.
- Per Business Quant, the three latest LUNG Non-Current Deferred Tax Liability figures stand at $69000.0 (Q4 2025), $47000.0 (Q3 2025), and $41000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Pulmonx | 67.30 Mn | -2.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 69,000.00 |
| Dec 31, 2025 | 69,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Sep 30, 2025 | 47,000.00 |
| Jun 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 41,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Mar 31, 2025 | 79,000.00 |
| Dec 31, 2024 | 87,000.00 |
| Dec 31, 2024 | 87,000.00 |
| Sep 30, 2024 | 129,000.00 |
| Sep 30, 2024 | 129,000.00 |
| Jun 30, 2024 | 118,000.00 |
| Jun 30, 2024 | 118,000.00 |
| Mar 31, 2024 | 140,000.00 |
| Mar 31, 2024 | 140,000.00 |
| Dec 31, 2023 | 114,000.00 |
| Dec 31, 2023 | 114,000.00 |
| Sep 30, 2023 | 97,000.00 |
| Sep 30, 2023 | 97,000.00 |
| Jun 30, 2023 | 94,000.00 |
| Jun 30, 2023 | 94,000.00 |
| Mar 31, 2023 | 71,000.00 |
| Mar 31, 2023 | 71,000.00 |
| Dec 31, 2022 | 94,000.00 |
| Dec 31, 2022 | 94,000.00 |
| Sep 30, 2022 | 51,000.00 |
| Sep 30, 2022 | 51,000.00 |
| Jun 30, 2022 | 47,000.00 |
| Jun 30, 2022 | 47,000.00 |
| Mar 31, 2022 | 53,000.00 |
| Mar 31, 2022 | 53,000.00 |
| Dec 31, 2021 | 37,000.00 |
| Dec 31, 2021 | 37,000.00 |
| Sep 30, 2021 | 70,000.00 |
| Sep 30, 2021 | 70,000.00 |
| Jun 30, 2021 | 71,000.00 |
| Jun 30, 2021 | 71,000.00 |
| Mar 31, 2021 | 71,000.00 |
| Mar 31, 2021 | 71,000.00 |
| Dec 31, 2020 | 62,000.00 |
| Dec 31, 2020 | 62,000.00 |
| Sep 30, 2020 | 54,000.00 |
| Sep 30, 2020 | 54,000.00 |
| Dec 31, 2019 | 43,000.00 |
| Dec 31, 2019 | 43,000.00 |